Knoll Capital Management as of June 30, 2020
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 19 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 35.8 | $62M | 858k | 72.39 | |
| Corbus Pharmaceuticals Hldgs | 24.4 | $42M | 5.0M | 8.39 | |
| Applied Therapeutics (APLT) | 13.3 | $23M | 650k | 35.36 | |
| Abeona Therapeutics | 4.7 | $8.2M | 2.9M | 2.85 | |
| Orgenesis | 4.6 | $8.0M | 1.3M | 6.08 | |
| Eiger Biopharmaceuticals | 2.9 | $5.1M | 525k | 9.64 | |
| Anavex Life Sciences Corp Com New (AVXL) | 2.1 | $3.6M | 724k | 5.00 | |
| Exicure | 1.8 | $3.1M | 1.3M | 2.40 | |
| Entera Bio SHS (ENTX) | 1.7 | $3.0M | 1.7M | 1.73 | |
| Aldeyra Therapeutics (ALDX) | 1.4 | $2.4M | 569k | 4.17 | |
| Blackstone Group Com Unit Ltd | 1.3 | $2.2M | 40k | 56.15 | |
| CenturyLink | 1.3 | $2.2M | 220k | 9.87 | |
| Soligenix | 0.9 | $1.6M | 788k | 2.01 | |
| Molecular Templates | 0.9 | $1.5M | 114k | 13.52 | |
| Dow (DOW) | 0.7 | $1.2M | 30k | 40.77 | |
| Catasys Com Par | 0.6 | $1.1M | 43k | 25.49 | |
| Bioxcel Therapeutics (BTAI) | 0.6 | $1.1M | 20k | 53.50 | |
| Corteva (CTVA) | 0.5 | $811k | 30k | 27.03 | |
| Dupont De Nemours (DD) | 0.5 | $785k | 15k | 52.33 |
